Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Ophthalmology therapeutics Market Research Reports

Titlepublishedprice

Global Latanoprost Sales Market Report 2017

By QYResearch Group
"...... ries, with sales, price, revenue and market share for each player in these regions, covering - Pfizer - Teva Pharmaceuticals - Greenstone - Novartis - Mylan - Taj Pharmaceuticals - Apotex - Sun ......"
13-Jan-2017$4000

China Ophthalmic Drug Market Research Report 2017

By QYResearch Group
"...... manufacturer, covering - Novartis - Allergan - Santen - Pfizer - Merck - Roche - Bayer - Senju - Regeneron - Valeant - Ozurdex Market Segment by Regions (pro......"
13-Jan-2017$3200

Glaucoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... and the market and pipeline status of the drugs around the Glaucoma to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight's Report provides the h......"
01-Jan-2017$2000

Bacterial Conjunctivitis-Pipeline Insights, 2017

By Delve Insight
"...... y, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA &......"
01-Jan-2017$1250

Retinal Degeneration-Pipeline Insights, 2017

By Delve Insight
"...... linical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA des......"
01-Jan-2017$1250

Retinal Vein Occlusion-Pipeline Insights, 2017

By Delve Insight
"...... re-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA......"
01-Jan-2017$1250

Retinitis Pigmentosa (Retinitis)-Pipeline Insights, 2017

By Delve Insight
"...... cluding Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, pa......"
01-Jan-2017$1250

Retinopathy Of Prematurity-Pipeline Insights, 2017

By Delve Insight
"...... overy, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USF......"
01-Jan-2017$1250

Macular Edema-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... to understand the market and pipeline status of the drugs around the Macular Edema to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight's Report......"
01-Jan-2017$2000

Blepharitis-Pipeline Insights, 2017

By Delve Insight
"...... e I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details......."
01-Jan-2017$1250

Avail upto 50% Discount on below Publisher Reports.